DOSSIER · UPDATED 18 NOV 2025

Synchron

Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.

synchron.com ↗Claim this profile

Founded: 2010
Headcount: 183
Open roles: 0
Last raised: Series C · $75M

SECTION I · THE BRIEF

Inside Synchron

Brief #53260Updated 18 NOV 2025CAMPBELLKHOSLA VENTURESSERIES C

Employbl Dossier

Synchron

Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.

Founded: 2010
Headcount: 183
Open roles: 0
Last raised: Series C · $75M

Section II · Premium ProfileMembers only

01Engineering interview process at SynchronLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Synchron brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Nicholas Opie

Researcher ORCID ID = 0000-0002-0342-9457

University of MelbourneSynchronSmartStentHead of Vascular Bionics Laboratory, The University of MelbourneCentre for Eye Research Australia (CERA)Murdoch Childrens Research InstituteMelbourne Business SchoolUniversity of MelbourneMonash UniversityScotch College

OPEN ROLES

Hiring at Synchron

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $130,000,000

Synchron's Investors

Khosla Ventures

Synchron Funding Rounds

Series C
$75,000,000
Dec 15, 2022
Series C
$75,000,000
Dec 14, 2022
Series C Investors
Arch Venture Partners
Forepont Capital Partners
NeuroTechnology Investors
Gates Frontier Fund
Shanda Group
ID8 Investments
Greenoaks Capital
University of Melbourne
Bezos Expeditions
Moore Strategic Ventures
Alumni Ventures Group
Khosla Ventures
METIS Innovative
Reliance Industries
Project X
General Advance
Subversive Capital
Castor Ventures
Green D Ventures
Series B
$40,000,000
Jun 3, 2021
Series B
$40,000,000
Jun 2, 2021
Series B Investors
Khosla Ventures
ID8 Investments
NeuroTechnology Investors
METIS Innovative
Shanda Group
General Advance
re.Mind Capital
University of Melbourne
Subversive Capital
Tom Reardon
Forepont Capital Partners
Arani Bose
Series A
$10,000,000
Apr 4, 2017
Series A
$10,000,000
Apr 3, 2017
Series A Investors
NeuroTechnology Investors
DARPA
Series Unknown
$5,000,000
Jan 28, 2005
Series Unknown
$5,000,000
Jan 27, 2005
Series Unknown Investors
Sigma Partners